The Center for Drug Evaluation and Research (CDER) Center for Clinical Trial Innovation (C3TI) is a central hub that supports innovative approaches to clinical trials that are designed to improve the efficiency of drug development. C3TI aims to promote existing CDER programs and spur future clinical trial innovation activities through enhanced communication and collaboration.
C3TI will enable internal and external parties to access information on clinical trial innovation efforts more easily, engage in collaborations, identify resources that can further support the use of innovative modalities, and find development programs where a concerted approach to the use of clinical trial innovations would be impactful. The goals of these efforts are to help those involved in clinical research in staying current with clinical trial innovations, improve the efficiency and effectiveness of clinical trials, help increase the participation of populations in clinical trials, and, in turn, accelerate the development of safe and effective new drugs.
C3TI is governed by leadership from the Office of the Center Director, Office of Communications, Office of Compliance, Office of Medical Policy, Office of New Drugs and Office of Translational Sciences.
Connect with us
Email us at CDERclinicaltrialinnovation@fda.hhs.gov
-
Content current as of:
05/17/2024
-
Regulated Product(s)
Topic(s)
